C07K 14/015
Parvoviridae
Official title: Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
C07K14/015 (Parvoviridae) appears on 42 US grants and 78 published applications in this corpus.
Search patents in C07K- Granted patents
- 42
- Published applications
- 78
- Assignees
- 42
- Inventors
- 179
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 3 | 4 |
| 2018 | 1 | 5 |
| 2019 | 1 | 8 |
| 2020 | 2 | 2 |
| 2021 | 6 | 12 |
| 2022 | 2 | 4 |
| 2023 | 3 | 8 |
| 2024 | 9 | 10 |
| 2025 | 10 | 9 |
| 2026 | 5 | 11 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof15 Sep 2026US 12,735,459 B2Genzyme Corporation
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Capsid variants and methods of using the same16 Jun 2026US 12,655,180 B2Dyno Therapeutics, Inc.
- Scalable method for recombinant AAV production28 Apr 2026US 12,612,644 B2REGENXBIO Inc.
- Capsid variants and methods of using the same20 Jan 2026US 12,528,841 B2Dyno Therapeutics, Inc.
- Nannochloropsis-producing viruses and methods and compositions for making the same1 Oct 2026US 2026/0297502 A1Insmed Incorporated
- Adeno-associated virus vector encoding connexin 26 and uses thereof17 Sep 2026US 2026/0275381 A1
- Parvovirus compositions and related methods for gene therapy10 Sep 2026US 2026/0265310 A1Carbon Biosciences, Inc.
- An aav2-vector variant for targeted transfer of genes3 Sep 2026US 2026/0258448 A1Universitaetsklinikum Hamburg-Eppendorf
- Novel capsid protein variant and use thereof6 Aug 2026US 2026/0226111 A1
Most cited
By later US patents
- AAV vectors with high transduction efficiency and uses thereof for gene therapy57US 9,725,485 B2University of Florida Research Foundation, Inc. · 2017
- AAV vectors targeted to oligodendrocytes37US 9,636,370 B2The University of North Carolina at Chapel Hill · 2017
- Capsid-modified rAAV vector compositions and methods therefor33US 10,011,640 B2University of Florida Research Foundation, Inc. · 2018
- Mutated structural protein of a parvovirus32US 9,624,274 B2Ludwig-Maximilians-Universitaet · 2017
- Capsid-modified rAAV vector compositions and methods therefor11US 10,815,279 B2University of Florida Research Foundation, Inc. · 2020